Hedda Wardemann

Hedda Wardemann

Auto-generated profile, based on publicly available information

Hedda Wardemann

B Cell Immunology, German Cancer Research Center (DKFZ), Heidelberg, Germany

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 October 2021 in Nature
Verified
Journal Article
Closed access
PDF file
TRTim Rollenske
Tim Rollenske
SBSophie Burkhalter
Sophie Burkhalter
LMLukas Muerner
Lukas Muerner
SGStephan von Gunten
Stephan von Gunten
JLJolanta Lukasiewicz
Jolanta Lukasiewicz
AMAndrew J. Macpherson
Andrew J. Macpherson

14 May 2018 in Nature Immunology
Verified
Journal Article
Closed access
PDF file
TRTim Rollenske
Tim Rollenske
VSValeria Szijarto
Valeria Szijarto
JLJolanta Lukasiewicz
Jolanta Lukasiewicz
LGLuis M. Guachalla
Luis M. Guachalla
KSKatarina Stojkovic
Katarina Stojkovic
HWHedda Wardemann
Hedda Wardemann

9 February 2018 in Science Immunology
Verified
Journal Article
Closed access
PDF file
RMRajagopal Murugan
Rajagopal Murugan
LBLisa Buchauer
Lisa Buchauer
GTGianna Triller
Gianna Triller
CKCornelia Kreschel
Cornelia Kreschel
GCGiulia Costa
Giulia Costa
HWHedda Wardemann
Hedda Wardemann
Affinity maturation, the clonal selection and expansion of antigen-activated B cells expressing somatically mutated antibody variants that develop during T cell–dependent germinal center reactions, is considered pivotal for efficient development of protective B cell memory responses to infection and vaccination. Repeated antigen exposure promotes affinity maturation but each time also recruits antigen-reactive naïve B cells into the response. Here, we determined the relative impact of affinity maturation versus antigen-mediated clonal selection of naïve B cells to mount potent B cell memory responses in humans after repeated exposure to a complex pathogen, the malaria parasite Plasmodium falciparum (Pf). Using single-cell immunoglobulin (Ig) gene sequencing and production of recombinant monoclonal antibodies, we analyzed the origin, development, and quality of memory B cell responses to Pf circumsporozoite protein (PfCSP), the major sporozoite surface protein. We show that after repeated immunization of Pf-naïve volunteers with infectious Pf sporozoites (PfSPZ Challenge) under chloroquine prophylaxis (PfSPZ-CVac), the clonal selection of potent germline and memory B cell precursors against the central PfCSP NANP repeat outpaces affinity maturation because the majority of Ig gene mutations are affinity-neutral. Mathematical modeling explains how the efficiency of affinity maturation decreases strongly with antigen complexity. Thus, in the absence of long-term exposure, the frequency of antigen-reactive precursors and likelihood of their activation rather than affinity maturation will determine the quality of anti-PfCSP memory B cell responses. These findings have wide implications for the design of vaccination strategies to induce potent B cell memory responses against PfCSP and presumably other structurally complex antigens.

11 October 2016 in EMBO Molecular Medicine
Verified
Journal Article
Open access
PDF file
NZNatalie Zimmermann
Natalie Zimmermann
VTVerena Thormann
Verena Thormann
BHBo Hu
Bo Hu
AKAnne‐Britta Köhler
Anne‐Britta Köhler
AIAki Imai‐Matsushima
Aki Imai‐Matsushima
HWHedda Wardemann
Hedda Wardemann
Accumulating evidence from experimental animal models suggests that antibodies play a protective role against tuberculosis (TB). However, little is known about the antibodies generated upon Mycobacterium tuberculosis (MTB) exposure in humans. Here, we performed a molecular and functional characterization of the human B‐cell response to MTB by generating recombinant monoclonal antibodies from single isolated B cells of untreated adult patients with acute pulmonary TB and from MTB‐exposed healthcare workers. The data suggest that the acute plasmablast response to MTB originates from reactivated memory B cells and indicates a mucosal origin. Through functional analyses, we identified MTB inhibitory antibodies against mycobacterial antigens including virulence factors that play important roles in host cell infection. The inhibitory activity of anti‐MTB antibodies was directly linked to their isotype. Monoclonal as well as purified serum IgA antibodies showed MTB blocking activity independently of Fc alpha receptor expression, whereas IgG antibodies promoted the host cell infection. Together, the data provide molecular insights into the human antibody response to MTB and may thereby facilitate the design of protective vaccination strategies. ![][1] Antibodies against Mycobacterium tuberculosis (MTB) may protect from infection and could be of therapeutic use, but this was never determined. This work identifies and characterizes anti‐MTB antibodies from patients. EMBO Mol Med (2016) 8: 1325–1339 [1]: /embed/graphic-1.gif

1 December 2017 in Immunity
Verified
Journal Article
Closed access
GTGianna Triller
Gianna Triller
SSStephen W. Scally
Stephen W. Scally
GCGiulia Costa
Giulia Costa
MPMaria Pissarev
Maria Pissarev
CKCornelia Kreschel
Cornelia Kreschel
HWHedda Wardemann
Hedda Wardemann

22 June 2018 in Science
Verified
Journal Article
Open access
PDF file
KIKatharina Imkeller
Katharina Imkeller
SSStephen W. Scally
Stephen W. Scally
ABAlexandre Bosch
Alexandre Bosch
GMGemma Pidelaserra Martí
Gemma Pidelaserra Martí
GCGiulia Costa
Giulia Costa
HWHedda Wardemann
Hedda Wardemann
Surface antibody maturation: Affinity maturation in B cells generates antibodies with increasingly enhanced antigen-binding properties. Imkeller et al. investigated the maturation of human B cells that express protective antibodies against the circumsporozoite protein of the malaria-causing parasite Plasmodium falciparum (PfCSP). The repetitive structure of PfCSP induces mutations in B cells, facilitating direct interactions between two repeat-bound antibodies against PfCSP, which enhance antigen affinity and B cell activation. Such interactions may optimize binding and promote clustering of surface antibodies in general. Science , this issue p. 1358